Akili Interactive to cut 30% of its staff
The prescription digital therapeutics company will also put non-ADHD products in development on hold to “conserve capital and focus.”
The prescription digital therapeutics company will also put non-ADHD products in development on hold to “conserve capital and focus.”
Go to Source
2023-01-18 21:16
Except for the headline, this story has not been edited by Healthcare Central is published from a syndicated feed.
